Akin advised Vista Credit Partners, and Latham & Watkins advised VideoAmp. VideoAmp announced $150 million in Series G funding led by Vista Credit Partners. The funding...
Vista Credit Partners’ $150 Million Equity Investment in VideoAmp
Ascendis Pharma’s $150 Million Royalty Funding Agreement with Royalty Pharma
Latham & Watkins and Mazanti-Andersen acted as legal advisors to Ascendis on the transaction, while Goodwin Procter, Kromann Reumert and Fenwick & West acted as legal...
MindMed’s Senior Secured Credit Facility With K2 HealthVentures LLC
Latham & Watkins advises MindMed in growth financing with K2 HealthVentures. Mind Medicine Inc. (MindMed), a clinical stage biopharmaceutical company developing novel product candidates to treat...
Heron Therapeutics’ Capital Credit Facility Agreement With Hercules Capital
Latham & Watkins advises on Heron Therapeutics’ working capital credit facility. Heron Therapeutics, Inc. (Heron), a commercial-stage biotechnology company focused on improving the lives of patients...
Vox Media’s Growth Financing Transaction
Latham & Watkins Advises Vox Media, Publisher of Editorial Properties Including Vox, SB Nation, New York Magazine, The Dodo, and The Verge, in Late-Stage Growth Financing...
SiteMinder’s $20 million Revolving Credit Facility
Latham & Watkins advised SiteMinder on the financing. SiteMinder announced a financing consisting of a $20 million revolving credit facility. HSBC Ventures USA Inc. acted as...
Yield Engineering Systems’ $55 Million IP-Backed Financing from Aon
Latham & Watkins advised YES on the transaction. Yield Engineering Systems (YES) has announced a $55 million IP-backed financing from a fund managed by Aon Advantage...
Niemann v. Carlsen
Latham & Watkins, supported in the litigation by local Missouri counsel Husch Blackwell, achieved a decisive victory in the high-profile defamation and antitrust lawsuit brought in...
Omada Health’s $80 Million Growth Financing
Latham & Watkins advises Omada Health on growth financing. Omada Health, Inc., a virtual-first healthcare provider that implements clinically-validated behavior change protocols for individuals living with...
Gurnet Point Capital’s Acquisition of Paratek Pharmaceuticals
Latham & Watkins advises Gurnet Point Capital in acquisition of Paratek Pharmaceuticals. Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of...
NextRoll’s $50 Million Financing Deal From Capital IP
Latham & Watkins advises NextRoll in US$50 million financing deal from Capital IP. NextRoll, the San Francisco-based marketing technology company delivering products for ambitious marketers to...
Tipalti’s $150 Million Growth Financing
Latham & Watkins and Gornitzky & Co. advise Hercules on the financing. Tipalti announced it has raised $150 million in incremental growth financing from JPMorgan Chase...